Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | ||||
| Accounts receivable | 435 | -139 | 37 | -120 |
| Accounts payable and accrued liabilities | N/A | -51 | 51 | N/A |
| Other Working Capital | 639 | -450 | 88 | -46 |
| Other Operating Activity | -1,721 | -161 | -395 | -551 |
| Operating Cash Flow | $-647 | $-801 | $-219 | $-717 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -12 | -7 | 0 | -1 |
| Other Investing Activity | 16 | -16 | 0 | 19 |
| Investing Cash Flow | $4 | $-23 | $0 | $18 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 2,109 | 2,000 | 141 | 142 |
| Financing Cash Flow | $2,109 | $2,000 | $141 | $142 |
| Exchange Rate Effect | N/A | -1 | 1 | N/A |
| Beginning Cash Position | 1,312 | 137 | 214 | 769 |
| End Cash Position | 2,778 | 1,312 | 137 | 214 |
| Net Cash Flow | $1,466 | $1,176 | $-78 | $-557 |
| Free Cash Flow | ||||
| Operating Cash Flow | -647 | -801 | -219 | -717 |
| Capital Expenditure | -12 | N/A | N/A | -1 |
| Free Cash Flow | -659 | -801 | -219 | -718 |